HALO logo
halo search icon
Mesoblast Limited Sponsored ADR
Mesoblast Limited Sponsored ADR
MESO · NAS

Mesoblast Limited Sponsored ADR

US$14.52

Price Arrow-0.03 (-0.206%)
20/05/2026 04:00:01 PM
All-ConsensusHammer Bearish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Mesoblast Limited Sponsored ADR Overview

MESO Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About MESO

icon

Telephone

61.3.9639.6036

icon

Address

Level 38, 55 Collins Street, Melbourne, Victoria (VIC) 3000

Description

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.

MESO Price Chart

Key Stats

Market Cap

US$1.87B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 9.88 - 21.5

Trade Value (12mth)

US$912,677.00

1 week

-2.94%

1 month

-10.07%

YTD

-19.88%

1 year

29.22%

All time high

97.65

Key Fundamentals

EPS 3 yr Growth

-36.70%

EBITDA Margin

-326.40%

Operating Cashflow

-$56m

Free Cash Flow Return

-9.00%

ROIC

-16.30%

Interest Coverage

-2.40

Quick Ratio

1.80

Other Data

Shares Outstanding (Fully Diluted)

129m

HALO Sector

Healthcare

Next Company Report Date

02-Sep-26

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

MESO Announcements

Latest Announcements

DateAnnouncements
30 April 26
29 April 26
29 April 26
17 April 26
15 April 26

MESO Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-1.05-0.89-0.84locklocklock
EPS (Fully Diluted)
$locklocklocklock-1.05-0.89-0.84locklocklock
Growth
%locklocklocklock21.614.55.6locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Mesoblast Limited Sponsored ADR (MESO:NAS)?
Halo FAQ
The current share price of Mesoblast Limited Sponsored ADR (MESO:NAS) is USD$14.52.
What is the 52-week high share price for Mesoblast Limited Sponsored ADR (MESO:NAS)?
Halo FAQ
The 52-week high share price for Mesoblast Limited Sponsored ADR (MESO:NAS) is USD$21.50.
What is the 52-week low share price for Mesoblast Limited Sponsored ADR (MESO:NAS)?
Halo FAQ
The 52-week low share price for Mesoblast Limited Sponsored ADR (MESO:NAS) is USD$9.88.
What is the dividend yield for Mesoblast Limited Sponsored ADR (MESO:NAS)?
Halo FAQ
Mesoblast Limited Sponsored ADR (MESO:NAS) does not pay a dividend.
What was Mesoblast Limited Sponsored ADR (MESO:NAS) last dividend payment?
Halo FAQ
Mesoblast Limited Sponsored ADR (MESO:NAS) does not pay a dividend.
What is the franking level for Mesoblast Limited Sponsored ADR (MESO:NAS)?
Halo FAQ
Mesoblast Limited Sponsored ADR (MESO:NAS) has a franking level of 0.00%.
In which sector is Mesoblast Limited Sponsored ADR (MESO:NAS) classified?
Halo FAQ
Mesoblast Limited Sponsored ADR (MESO:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.